Silver-doped pseudowollastonite synthesized from rice husk ash: Antimicrobial evaluation, bioactivity and cytotoxic effects on human mesenchymal stem cells
Source abstract
Abstract
Abstract Research into biomaterials has grown rapidly in recent years due to the clinical need for organ and tissue replacement and regeneration. One of the most serious complications in orthopaedic implants is surgical site infection. Therefore, many attempts have been made to develop biocompatible materials with antibacterial properties. In this study, a newly-synthesized pseudowollastonite (PSW), synthesized from rice husk ash and a limestone precursor, was incorporated with different concentrations of silver (Ag) and sintered to enhance the antimicrobial activity and biocompatibility of pseudowollastonite-silver (PSW/Ag) biocomposites. The antibacterial test revealed that PSW, with the addition of silver up to 5 wt%, was able to inhibit the growth and reproduction of bacteria. The bioactivity test for the PSW/5 wt% Ag biocomposite also displayed the existence of an apatite peak in the X-ray diffraction pattern. The apatite microstructure was observed with FESEM-EDX after seven days of immersion in simulated body fluid (SBF) solutions. Cytotoxic effects of the composite were observed after 24 h of incubation in 10% leachate containing hMSC cells. After 72 h of incubation, the survival cells were proliferated considerably. The viability was shown with the positive increment after 72 h of incubation for PSW with the addition of 5 wt% Ag. Thus, although PSW/5 wt% Ag synthesized from the rice husk ash and limestone was shown to be bioactive and have good antimicrobial properties, the composite still needs to be optimized to control cytotoxic effects.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Orthopedic Infections and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Synthesis, characterization and bioactivity studies of calcium silicate, bioceramics10.4028/www.scientific.net/AMR.584.479 ↗
2. Bioactive calcium silicate ceramics and coatings10.1016/j.biopha.2008.07.051 ↗
3. Novel fast-setting calcium silicate bone cements with high bioactivity and enhanced osteogenesis in vitro10.1039/b819033j ↗
4. Mechanism of apatite formation on β-wollastonite sample surface synthesized from rice husk ash10.17576/jsm-2016-4512-01 ↗
5. Crystal structures of CaSiO3 polymorphs control growth and osteogenic differentiation of human mesenchymal stem cells on bioceramic surfaces10.1039/c3bm60034c ↗
6. Influence of sterilization techniques on the in vitro bioactivity of pseudowollastonite10.1111/j.1551-2916.2006.01108.x ↗
7. Dissolution and mineralization of plasma-sprayed wollastonite coatings with different crystallinity10.1016/j.surfcoat.2004.07.114 ↗
8. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era10.1016/j.jconrel.2011.07.002 ↗
9. In vitro and in vivo antimicrobial properties of silver-containing hydroxyapatite prepared via ultrasonic spray pyrolysis route10.1016/j.msec.2013.08.026 ↗
10. Silver nanoparticles-modified films versus biomedical device-associated infections10.1002/wnan.113 ↗
11. Development of nanosized silver-substituted apatite for biomedical applications: a review, nanomedicine nanotechnology
12. Characterization of enhanced antibacterial effects of novel silver nanoparticles
13. Nanosilver: a nanoproduct in medical application10.1016/j.toxlet.2007.10.004 ↗
14. Silver nanoparticles as nano-antimicrobials: bioactivity, benefits and bottlenecks10.1007/978-3-642-24428-5_7 ↗
15. Scenery of Staphylococcus implant infections in orthopedics10.2217/fmb.11.117 ↗
16. Silver resistance in Gram-negative bacteria: a dissection of endogenous and exogenous mechanisms10.1093/jac/dku523 ↗
17. Synthesis and antimicrobial activity of silver-doped hydroxyapatite nanoparticles10.1155/2013/916218 ↗
18. Ultra-trace silver-doped hydroxyapatite with non-cytotoxicity and effective antibacterial activity10.1016/j.msec.2015.05.078 ↗
19. Calcium phosphate coating containing silver shows high antibacterial activity and low cytotoxicity and inhibits bacterial adhesion10.1016/j.msec.2009.09.015 ↗
20. Investigation on bioactivity, biocompatibility, thermal behavior and antibacterial properties of calcium silicate glass coatings containing Ag10.1016/j.jnoncrysol.2015.04.037 ↗
21. Biological and antibacterial properties of plasma sprayed wollastonite/silver coatings10.1002/jbm.b.31434 ↗
22. In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating10.1016/j.biomaterials.2006.07.003 ↗
23. Preparation and antibacterial effect of plasma sprayed wollastonite coatings loading silver10.1016/j.apsusc.2008.06.143 ↗
24. The suitability of rice straw ash as a precursor for synthesizing β-wollastonite10.4028/www.scientific.net/MSF.846.216 ↗
25. Low temperature production of wollastonite from limestone and silica sand through solid-state reaction10.1016/j.ceramint.2013.12.004 ↗
26. Synthesis and characterization of nano-wollastonite from rice husk ash and limestone10.4028/www.scientific.net/MSF.756.43 ↗
27. How useful is SBF in predicting in vivo bone bioactivity?10.1016/j.biomaterials.2006.01.017 ↗
28. Influence of Ag content on the antibacterial properties of SiC doped hydroxyapatite coatings10.1016/j.ceramint.2015.09.143 ↗
29. Synthesis of antimicrobial monophase silver-doped hydroxyapatite nanopowders for bone tissue engineering10.1016/j.apsusc.2010.12.113 ↗
30. Synthesis, phase stability of hydroxyapatite-silver composite with antimicrobial activity and cytocompatability10.1016/j.ceramint.2014.03.075 ↗
31. A mechanistic study on the antibacterial behavior of silver doped bioceramic10.1016/j.jallcom.2014.12.158 ↗
32. Synthesis and characterization of bovine femur bone hydroxyapatite containing silver nanoparticles for the biomedical applications10.1007/s11051-010-9944-z ↗
33. Research of antibacterial activity on silver containing yttria-stabilized – zirconia bioceramic10.1016/j.ceramint.2012.10.186 ↗
34. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 ↗
35. Fabrication of silver nanoparticles and their antimicrobial mechanisms
36. Biomaterial-centered infection: microbial adhesion versus tissue integration10.1126/science.3629258 ↗
37. Preparation process of a highly resistant wollastonite bioceramics using local raw materials10.1007/s10973-012-2242-5 ↗
38. Effects of composition on crystallization behaviour and mechanical properties of bioactive glass-ceramics in the MgO-CaO-SiO2-P2O5 system10.1016/S0272-8842(99)00072-3 ↗
39. Bioactivity of wollastonite/aerogels composites obtained from a TEOS–MTES matrix10.1007/s10856-007-3312-2 ↗
40. Calcium orthophosphates in nature, biology and medicine10.3390/ma2020399 ↗
41. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release10.1016/j.jconrel.2004.10.016 ↗
42. Neuropathy caused by silver absorption from arthroplasty cement10.1016/S0140-6736(85)92230-5 ↗
43. The effect of varying Al2O3 percentage in hydroxyapatite/Al2O3 composite materials: morphological, chemical and cytotoxic evaluation10.1002/jbm.a.31377 ↗
44. Structural properties of silver doped hydroxyapatite and their biocompatibility10.1016/j.msec.2012.12.042 ↗
45. Biocompatibility assessment of polytetra uoroethylene/wollastonite composites using endothelial cells and macrophages10.1163/156856201753395734 ↗
46. Effects of pseudowollastonite (CaSiO3) bioceramic on in vitro activity of human mesenchymal stem cells10.1016/j.biomaterials.2010.06.043 ↗